BUY 1 GET 1 50% OFF
no code needed

every product, sitewide — no code, applied automatically at checkout

side-by-side research comparison

Tesamorelin vs BPC-157 + TB-500

Tesamorelin and BPC-157 + TB-500 come from different research areas and are studied in largely separate models — researchers usually compare them when scoping a broader protocol.

✓ both US-made · third-party tested · batch COA on every order

Last updated August 25, 2026

How do Tesamorelin and BPC-157 + TB-500 differ?

Tesamorelin (Synthetic GHRH analog · secretagogue research) is catalogued under weight & metabolic research; BPC-157 + TB-500 (Co-formulated two-peptide research blend) is catalogued under recovery & gut research. Verve lists 4 reported research applications for Tesamorelin and 5 for BPC-157 + TB-500. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.

Tesamorelin compared with BPC-157 + TB-500 across compound class, research area, supply format, purity standard, documentation, catalog price and stock.
fieldTesamorelinBPC-157 + TB-500
compound classSynthetic GHRH analog · secretagogue researchCo-formulated two-peptide research blend
research areaweight & metabolicrecovery & gut
reported research applications4 listed5 listed
supplied assingle compoundco-formulated blend
catalog sizes20mg20mg
purity standard99%+ by HPLC99%+ by HPLC
manufacturedUnited StatesUnited States
batch COApublished per lotpublished per lot
endotoxin-tested optionavailableavailable
co-formulated together innot co-formulatednot co-formulated
price from$214.49$171.49
availabilityin stockin stock

Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.

What is Tesamorelin and what is BPC-157 + TB-500?

Tesamorelin is classified as Synthetic GHRH analog · secretagogue research; BPC-157 + TB-500 as Co-formulated two-peptide research blend. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.

Tesamorelin

Synthetic GHRH analog · secretagogue research

Tesamorelin is a synthetic 44-amino-acid peptide, a stabilized analog of growth-hormone-releasing hormone (GHRH). Verve supplies it as a high-purity research compound for endocrine and secretagogue research.

full Tesamorelin profile →

BPC-157 + TB-500

Co-formulated two-peptide research blend

BPC-157 + TB-500 is a co-formulated research blend that combines two of the most frequently cited reference peptides in tissue-repair literature, BPC-157 / TB-500, in a single vial. BPC-157 is a synthetic pentadecapeptide derived from a partial sequence identified in human gastric juice; TB-500 is a synthetic 43-amino-acid peptide corresponding to an active fragment of thymosin beta-4, a naturally-occurring actin-binding protein.

full BPC-157 + TB-500 profile →

Which research models is each compound studied in?

Tesamorelin sits in weight & metabolic research and BPC-157 + TB-500 in recovery & gut research, so their listed models largely do not intersect. The table lists 4 reported research applications for Tesamorelin and 5 for BPC-157 + TB-500. Rows are per compound, not equivalences.

Reported research applications listed for Tesamorelin and for BPC-157 + TB-500. Entries are listed per compound; a shared row is not a claim that the two applications are equivalent.
Tesamorelin — reported research applicationsBPC-157 + TB-500 — reported research applications
GHRH-receptor and secretagogue researchMulti-compound tissue-repair research models
Endocrine-signaling research modelsCell-migration and wound-healing research
Peptide pharmacokinetics and stability researchAngiogenesis and vascular-signaling research
Metabolic research modelsActin-regulation and cytoskeletal research
Comparative research on blended versus single-peptide preparations

Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.

What sizes and prices does verve list for Tesamorelin and BPC-157 + TB-500?

Tesamorelin is listed from $214.49 and BPC-157 + TB-500 from $171.49. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.

Catalog sizes, single-vial prices and stock status for Tesamorelin and BPC-157 + TB-500.
compoundsize listedpriceavailability
Tesamorelin20mg$214.49in stock
BPC-157 + TB-50020mg$171.49in stock

Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.

shop the compounds →

Frequently asked questions about Tesamorelin and BPC-157 + TB-500

What is Tesamorelin?

Tesamorelin is a synthetic 44-amino-acid analog of growth-hormone-releasing hormone (GHRH). Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is Tesamorelin studied for in research?

It is used as a GHRH-receptor agonist model in secretagogue and endocrine-signaling research. Verve makes no human- or veterinary-use claims.

What is BPC-157 + TB-500?

BPC-157 + TB-500 is a co-formulated research blend of two well-characterized reference peptides, BPC-157 / TB-500, supplied in one vial. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is the BPC-157 / TB-500 blend studied for in research?

It is used in multi-compound cellular models covering tissue repair, cell migration, angiogenesis, and actin regulation, where both peptides are studied together. Verve makes no health claims.

related comparisons

verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.